thioridazine has been researched along with Briquet Syndrome in 1 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy of monotherapy with sertraline or its combinations with phenazepam or thioridazine in patients with somatoform disorders." | 3.83 | [The efficacy of benzodiazepines and low-potent antipsychotics as adjunctive therapy of somatoform disorders]. ( Pribytkov, AA, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pribytkov, AA | 1 |
1 other study available for thioridazine and Briquet Syndrome
| Article | Year |
|---|---|
[The efficacy of benzodiazepines and low-potent antipsychotics as adjunctive therapy of somatoform disorders].
Topics: Adult; Antipsychotic Agents; Anxiety; Benzodiazepines; Chemotherapy, Adjuvant; Drug Therapy, Combina | 2016 |